Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives.
Ottaiano A, Santorsola M, Circelli L, Trotta AM, Izzo F, Perri F, Cascella M, Sabbatino F, Granata V, Correra M, Tarotto L, Stilo S, Fiore F, Martucci N, Rocca A, Picone C, Muto P, Borzillo V, Belli A, Patrone R, Mercadante E, Tatangelo F, Ferrara G, Di Mauro A, Scognamiglio G, Berretta M, Capuozzo M, Lombardi A, Galon J, Gualillo O, Pace U, Delrio P, Savarese G, Scala S, Nasti G, Caraglia M. Ottaiano A, et al. Among authors: caraglia m. Cancers (Basel). 2023 Mar 17;15(6):1827. doi: 10.3390/cancers15061827. Cancers (Basel). 2023. PMID: 36980713 Free PMC article. Review.
The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE).
Facchini G, Caraglia M, Santini D, Nasti G, Ottaiano A, Striano S, Maiolino P, Ruberto M, Fiore F, Tonini G, Budillon A, Iaffaioli RV, Zeppetella GL. Facchini G, et al. Among authors: caraglia m. J Exp Clin Cancer Res. 2007 Sep;26(3):307-12. J Exp Clin Cancer Res. 2007. PMID: 17987788 Clinical Trial.
New treatment approaches in renal cell carcinoma.
Facchini G, Perri F, Caraglia M, Pisano C, Striano S, Marra L, Fiore F, Aprea P, Pignata S, Iaffaioli RV. Facchini G, et al. Among authors: caraglia m. Anticancer Drugs. 2009 Nov;20(10):893-900. doi: 10.1097/CAD.0b013e32833123d4. Anticancer Drugs. 2009. PMID: 19752718 Review.
Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome.
Franco R, Cantile M, Scala S, Catalano E, Cerrone M, Scognamiglio G, Pinto A, Chiofalo MG, Caracò C, Anniciello AM, Abbruzzese A, Caraglia M, Botti G. Franco R, et al. Among authors: caraglia m. Cancer Biol Ther. 2010 Mar 15;9(6):423-9. doi: 10.4161/cbt.9.6.10996. Epub 2010 Mar 20. Cancer Biol Ther. 2010. PMID: 20061818
Endocrine disruptors and female cancer: Informing the patients (Review).
Del Pup L, Mantovani A, Luce A, Cavaliere C, Facchini G, Di Francia R, Caraglia M, Berretta M. Del Pup L, et al. Among authors: caraglia m. Oncol Rep. 2015 Jul;34(1):3-11. doi: 10.3892/or.2015.3997. Epub 2015 May 20. Oncol Rep. 2015. PMID: 25998096 Review.
Drug-Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection.
Berretta M, Caraglia M, Martellotta F, Zappavigna S, Lombardi A, Fierro C, Atripaldi L, Muto T, Valente D, De Paoli P, Tirelli U, Di Francia R. Berretta M, et al. Among authors: caraglia m. Front Pharmacol. 2016 Mar 30;7:71. doi: 10.3389/fphar.2016.00071. eCollection 2016. Front Pharmacol. 2016. PMID: 27065862 Free PMC article. Review.
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment.
Misso G, Zarone MR, Grimaldi A, Di Martino MT, Lombardi A, Kawasaki H, Stiuso P, Tassone P, Tagliaferri P, Caraglia M. Misso G, et al. Among authors: caraglia m. Curr Drug Targets. 2017;18(1):35-55. doi: 10.2174/1389450117666160606104208. Curr Drug Targets. 2017. PMID: 27280795 Review.
528 results